Cogmotiv is a privately held, early-stage biotech company based in Vienna, Austria, dedicated to addressing apathy in dementia – one of the most disabling and prevalent symptoms of the disease.
Our Team
We bring together scientific rigor, translational experience and execution-focused leadership to move discovery efficiently from research to clinical development, with a strong commitment to patient impact and unmet medical needs.
Managing Team
Founder & CEO, molecular biologist with over 15 years of experience in neuroscience and biochemistry. Jana leads Cogmotiv’s scientific strategy, project development and partnering activities.
Co-founder & COO, a senior life science executive with 20+ years of experience in drug development, leading programs from early discovery to early clinical development. Petra supports Cogmotiv’s operational strategy, project execution and development planning.
CSO & Inventor, a MD and internationally recognised scientist with 700+ publications, supporting Cogmotiv’s scientific direction and CM01 development strategy.
Advisors
Dr. Johann Leban is a medicinal and synthetic chemist with 40+ years of experience in peptide and small-molecule drug discovery across academia and industry. He has contributed to multiple drug candidates in clinical development or commercial use and supports Cogmotiv’s medicinal chemistry strategy.
Dr. Predrag Kalaba is a medicinal chemist with expertise in dopamine transporter biology and atypical DAT inhibitors. He supports Cogmotiv’s R&D strategy and CM01 development.
